Login / Signup
Dajana Kolanovic
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 5
Top Topics
Cell Death
Squamous Cell
Cancer Therapy
Helicobacter Pylori Infection
Top Venues
Journal of translational medicine
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Francesca Rosato
,
Rajeev Pasupuleti
,
Jana Tomisch
,
Ana Valeria Meléndez
,
Dajana Kolanovic
,
Olga N Makshakova
,
Birgit Wiltschi
,
Winfried Römer
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death.
Journal of translational medicine
20 (1) (2022)
Francesca Rosato
,
Rajeev Pasupuleti
,
Jana Tomisch
,
Ana Valeria Meléndez
,
Dajana Kolanovic
,
Olga N Makshakova
,
Birgit Wiltschi
,
Winfried Römer
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death.
Journal of translational medicine
20 (1) (2022)
Francesca Rosato
,
Rajeev Pasupuleti
,
Jana Tomisch
,
Ana Valeria Meléndez
,
Dajana Kolanovic
,
Olga N Makshakova
,
Birgit Wiltschi
,
Winfried Römer
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death.
Journal of translational medicine
20 (1) (2022)
Francesca Rosato
,
Rajeev Pasupuleti
,
Jana Tomisch
,
Ana Valeria Meléndez
,
Dajana Kolanovic
,
Olga N Makshakova
,
Birgit Wiltschi
,
Winfried Römer
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death.
Journal of translational medicine
20 (1) (2022)
Francesca Rosato
,
Rajeev Pasupuleti
,
Jana Tomisch
,
Ana Valeria Meléndez
,
Dajana Kolanovic
,
Olga N Makshakova
,
Birgit Wiltschi
,
Winfried Römer
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death.
Journal of translational medicine
20 (1) (2022)